Grünenthal Gmbh
Clinical trials sponsored by Grünenthal Gmbh, explained in plain language.
-
New pain pill GRT7041 enters first human tests
Symptom relief Recruiting nowThis early-stage trial tests a new oral drug called GRT7041 for pain treatment in 70 healthy volunteers. The main goal is to check safety and how the body handles the drug. Participants will take single or multiple doses and be monitored for about 6 to 8 weeks.
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
Healthy men needed to track how experimental drug exits the body
Knowledge-focused Recruiting nowThis study looks at how a single dose of an experimental drug called GRT6019 is processed and removed from the body. Ten healthy men aged 30 to 65 will provide urine and stool samples to measure the drug's breakdown products. The goal is to understand the drug's metabolism, not t…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated May 17, 2026 04:28 UTC